| 摘要 |
The compounds rubradirin, rubradirin B, rubradirin aglycone and the novel compounds protorubradirin, protorubradirin D, rubradirin D or pharmaceutically acceptable salts thereof can be used to treat humans infected with one or more than one strain of human immunodeficiency virus. |
